News and Trends 8 Mar 2023
Noema Pharma raises $112 million in Series B financing
Noema Pharma, a Swiss clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, has closed an oversubscribed Series B financing round, raising CHF 103 million ($112 million) from new…